Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Calliditas Therapeutics (NASDAQ:CALT) stock rose 41.09% to $26.3 during Thursday's pre-market session. The market value of their outstanding shares is at $688.2 million.
  • Valneva (NASDAQ:VALN) stock moved upwards by 14.47% to $58.36. The company's market cap stands at $3.0 billion.
  • Trinity Biotech (NASDAQ:TRIB) stock increased by 13.09% to $1.9. The company's market cap stands at $39.7 million. As per the news, the Q3 earnings report came out yesterday.
  • Mesoblast (NASDAQ:MESO) shares increased by 11.46% to $5.54. The company's market cap stands at $717.3 million.
  • Evofem Biosciences (NASDAQ:EVFM) shares increased by 10.47% to $0.42. The market value of their outstanding shares is at $68.4 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) shares rose 8.76% to $17.75. The company's market cap stands at $349.8 million.
  •  

Losers

  • Syndax Pharmaceuticals (NASDAQ:SNDX) shares fell 10.39% to $17.0 during Thursday's pre-market session. The market value of their outstanding shares is at $863.8 million.
  • Galera Therapeutics (NASDAQ:GRTX) stock fell 6.21% to $2.72. The market value of their outstanding shares is at $71.9 million.
  • BrainsWay (NASDAQ:BWAY) shares declined by 6.12% to $7.98. The company's market cap stands at $131.3 million.
  • Histogen (NASDAQ:HSTO) stock declined by 5.06% to $0.4. The market value of their outstanding shares is at $16.8 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares declined by 5.04% to $2.64. The company's market cap stands at $22.0 million.
  • ViewRay (NASDAQ:VRAY) shares fell 4.39% to $5.02. The market value of their outstanding shares is at $889.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.